Elbe Kliniken Stade-Buxtehude

Hospital


Location: Buxtehude / Stade, Germany (DE) DE

ISNI: 0000000405581967

ROR: https://ror.org/04psvb108

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. (2020) Zimmer L, Livingstone E, Hassel JC, Fluck M, Eigentler T, Loquai C, Haferkamp S, et al. Journal article Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) (2020) Steeb T, Wessely A, Alter M, Bayerl C, Bender A, Bruning G, Dabrowski E, et al. Journal article Oncological colorectal surgery during the COVID-19pandemic—a national survey (2020) Brunner M, Krautz C, Kersting S, Stinner B, Benz SR, Grützmann R, Weber G Journal article Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) Maurer M, Aberer W, Agondi R, Al-Ahmad M, Al-Nesf MA, Ansotegui I, Arnaout R, et al. Journal article Implementation of dupilumab in routine care of atopic eczema. Results from the German national registry TREATgermany (2020) Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Wollenberg A, Weisshaar E, et al. Journal article A phase I dose escalation and expansion study of intratumorally administered CV8102 as a single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution Profile of sunless tanning product users: Results from a nationwide representative survey (2019) Diehl K, Goerig T, Schilling L, Greinert R, Breitbart EW, Schneider S Journal article Optimistically biased perception of one's own skin cancer risk: Representative nationwide findings (2019) Diehl K, Goerig T, Osenbruegge N, Schilling L, Greinert R, Schneider S Journal article